Experience

Orgenesis Inc.

• United States
• Biotechnology
• 1 - 100 Employee

• Director

  • Jan 2022 - Present

  CAR-T cell, NK cell, Process & Analytical Method Development, CMO CAR-T cell, NK cell, Process & Analytical Method Development, CMO



Cellontech Co., Ltd.

• Seoul, Korea

• Production & Development Director

  • May 2016 - Dec 2021

  세포치료제 2개 제품 재허가 총괄 CTD 및 시험법 재설정 등 총괄 RMS (Regenerative Medical System) Production & Development Division for cell therapy & biomaterial medical devices 세포치료제 2개 제품 재허가 총괄 CTD 및 시험법 재설정 등 총괄 RMS (Regenerative Medical System) Production & Development Division for cell therapy & biomaterial medical devices



RMS Innovations UK

• Managing Director

  • Oct 2012 - Jan 2017

  영국 법인 법인장으로서 영국 내 세포치료제 영국 내 생산 및 판매 총괄영국을 기점으로 Class III 의료기기 치료재료 유럽 시장 진출 총괄RMS Innovations UK, part of the Sewon Cellontech group, are one of the leaders in the U.K market for regenerative medical technology.

• Technical Director

  • May 2009 - Sep 2012

  영국 내 Module 형 GMP Facilty Set-up 및 MHRA 인허가 총괄MHRA 'Specials' License 인증 총괄MHRA MIA(IMP) License 인증 총괄Set-up EU GMP facility in London, UK, and approved two GMP licenses from MHRA.Has collaborated with UK reputed consultant orthopaedic surgeons to develop UK and EU market.



Sewon Cellontech Co., Ltd.

• South Korea
• Biotechnology Research
• 1 - 100 Employee

• General Manager

  • Apr 2000 - Apr 2016

  국내 세포치료제 1호인 '콘드론' (자기유래 연골세포치료제) 개발 및 허가 자기 MSC 유래 뼈세포치료제인 '오스론' 개발 및 허가 Developed the 1st cell therapy product in Korea. Set up GMP facility in Korea. Transferred technologies to partners all around world. 국내 세포치료제 1호인 '콘드론' (자기유래 연골세포치료제) 개발 및 허가 자기 MSC 유래 뼈세포치료제인 '오스론' 개발 및 허가 Developed the 1st cell therapy product in Korea. Set up GMP facility in Korea. Transferred technologies to partners all around world.